2-189039508-G-A
Variant summary
Our verdict is Benign. The variant received -7 ACMG points: 0P and 7B. BP4_ModerateBS1_SupportingBS2
The NM_000393.5(COL5A2):c.3689C>T(p.Thr1230Ile) variant causes a missense change. The variant allele was found at a frequency of 0.0000242 in 1,613,950 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. T1230R) has been classified as Likely benign.
Frequency
Consequence
NM_000393.5 missense
Scores
Clinical Significance
Conservation
Publications
- Ehlers-Danlos syndromeInheritance: AD Classification: DEFINITIVE Submitted by: G2P
- Ehlers-Danlos syndrome, classic typeInheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, ClinGen
- Ehlers-Danlos syndrome, classic type, 2Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -7 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| COL5A2 | NM_000393.5 | c.3689C>T | p.Thr1230Ile | missense_variant | Exon 51 of 54 | ENST00000374866.9 | NP_000384.2 | |
| COL5A2 | XM_011510573.4 | c.3551C>T | p.Thr1184Ile | missense_variant | Exon 54 of 57 | XP_011508875.1 | ||
| COL5A2 | XM_047443251.1 | c.3551C>T | p.Thr1184Ile | missense_variant | Exon 56 of 59 | XP_047299207.1 | ||
| COL5A2 | XM_047443252.1 | c.3551C>T | p.Thr1184Ile | missense_variant | Exon 55 of 58 | XP_047299208.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| COL5A2 | ENST00000374866.9 | c.3689C>T | p.Thr1230Ile | missense_variant | Exon 51 of 54 | 1 | NM_000393.5 | ENSP00000364000.3 | ||
| COL5A2 | ENST00000618828.1 | c.2528C>T | p.Thr843Ile | missense_variant | Exon 44 of 47 | 5 | ENSP00000482184.1 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152184Hom.: 0 Cov.: 31 show subpopulations
GnomAD2 exomes AF: 0.0000160 AC: 4AN: 250610 AF XY: 0.0000221 show subpopulations
GnomAD4 exome AF: 0.0000260 AC: 38AN: 1461766Hom.: 0 Cov.: 32 AF XY: 0.0000289 AC XY: 21AN XY: 727182 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152184Hom.: 0 Cov.: 31 AF XY: 0.0000135 AC XY: 1AN XY: 74338 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
Familial thoracic aortic aneurysm and aortic dissection Uncertain:1
The p.T1230I variant (also known as c.3689C>T), located in coding exon 51 of the COL5A2 gene, results from a C to T substitution at nucleotide position 3689. The threonine at codon 1230 is replaced by isoleucine, an amino acid with similar properties. This amino acid position is well conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at